The American Kratom Association (AKA) has requested that popular health information site WebMD “stop all publishing and distribution of [Food and Drug Administration (FDA)] directed material regarding Mitragyna speciosa."
The pro-kratom consumer rights organization issued the request via a petition created on May 7th, 2021. They believe that as a top-ranking health authority, WebMD’s biased, anti-kratom information can cause medical professionals to develop an incorrect understanding of the plant.
In defense of kratom, the AKA pointed to the millions of Americans who safely use it. They also referenced how the FDA’s judgment had been questioned by another government organization, the Department of Health and Human Services (DHHS). That department concluded that the FDA was wrong about kratom and that scheduling the plant could cause many Americans to seek out more dangerous alternatives, such as opioid drugs. The DHHS also stated that further kratom research would be necessary to inform a future policy decision.
But the AKA didn't merely criticize WebMD's kratom information. They also offered to help improve it, suggesting in the petition that they meet with WebMD employees to “properly inform them on kratom.”
The AKA’s request also extends to other websites within the WebMD network, including Medscape, MedicineNet, eMedicine, eMedicineHealth, RxList, & OnHealth.
As of this writing, the AKA has not published any response from WebMD or WebMD CEO Robert Brisco. All American residents are eligible to sign the petition.